BDBM557764 (1S,3′R,6′R,7′S,11′S,12′R)-6-CHLORO-11′,12′-DIMETHYL-7′-(CIS-5-(2-OXA-6-AZASPIRO[3.3]HEPT-6-YL)-1,3-DIOXAN-2-YL)-3,4-DIHYDRO-2H,15′H-SPIRO[NAPHTHALENE-1,22′-[20]OXA[13]THIA[1,14]DIAZATETRACYCLO[14.7.2.0 3,6 .0 19,24 ]PENTACOSA[16,18,24]TRIEN]-15′-ONE 13′,13′-DIOXIDE::US11364248, Example 59
SMILES C[C@@H]1[C@@H](C)CCC[C@H]([C@H]2OC[C@@H](N3CC4(COC4)C3)CO2)[C@@H]2CC[C@H]2CN2C[C@@]3(CCCc4cc(Cl)ccc43)COc3ccc(cc32)C(=O)NS1(=O)=O
InChI Key InChIKey=LJSDZNCKKNDWCD-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 557764
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Human)
Amgen
US Patent
Amgen
US Patent
Affinity DataIC50: 0.319nMAssay Description:The inhibition of the Mcl-1/Bim interaction was measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. The recombinan...More data for this Ligand-Target Pair
